Insider Trading activities of Xbiotech Inc. (XBIT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xbiotech Inc. (XBIT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xbiotech Inc. since year 2005. Table 2 shows the detailed insider transactions of Xbiotech Inc. since 2005. The reporting company's ticker symbol is XBIT. The reporting company's CIK number is 1626878.
The total value of stock buying since 2005 is $11,922,590.
The total value of stock sales since 2005 is $2,995,216.
The total value of stock option exercises since 2005 is $605,341.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Xbiotech Inc. (XBIT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-09 0 $0 7,159 $26,395 0 $0
2019-06 1,200,000 $9,900,000 0 $0 0 $0
2019-03 51,425 $414,470 0 $0 0 $0
2019-02 115,575 $1,084,942 4,500 $45,000 4,500 $11,250
2019-01 900 $4,635 0 $0 0 $0
2018-12 36,202 $207,962 0 $0 50,000 $125,000
2018-11 2,900 $10,842 0 $0 0 $0
2018-10 0 $0 385,000 $1,155,000 0 $0
2018-09 0 $0 107,841 $347,681 0 $0
2018-08 0 $0 88,125 $350,702 0 $0
2018-07 0 $0 11,875 $52,857 0 $0
2018-03 0 $0 80,000 $378,072 80,000 $199,999
2017-05 0 $0 0 $0 240,000 $223,680
2016-11 0 $0 19,573 $293,595 19,573 $14,484
2016-09 0 $0 427 $6,405 427 $328
2016-05 21,500 $299,739 0 $0 0 $0
2015-12 0 $0 30,000 $314,309 30,000 $21,600
2015-11 0 $0 1,800 $25,200 1,800 $9,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Xbiotech Inc. insiders (XBIT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-09-06 Mckenzie W Thorpe (Director) Sale 7,159 3.69 26,395
2019-06-04 Rennes Fondation (10% Owner) Buy 1,200,000 8.25 9,900,000
2019-03-04 Rennes Fondation (10% Owner) Buy 16,426 7.91 129,929
2019-03-01 Rennes Fondation (10% Owner) Buy 34,999 8.13 284,541
2019-02-28 Rennes Fondation (10% Owner) Buy 5,302 8.19 43,423
2019-02-27 Rennes Fondation (10% Owner) Buy 5,273 8.13 42,869
2019-02-07 Shivaswamy Sushma (Chief Scientific Officer) Sale 4,500 10.00 45,000
2019-02-07 Shivaswamy Sushma (Chief Scientific Officer) Option Ex 4,500 2.50 11,250
2019-02-07 Rennes Fondation (10% Owner) Buy 40,000 10.00 400,000
2019-02-06 Rennes Fondation (10% Owner) Buy 65,000 9.21 598,650
2019-01-02 Rennes Fondation (10% Owner) Buy 900 5.15 4,635
2018-12-27 Mckenzie W Thorpe (Director) Buy 1,364 4.92 6,705
2018-12-27 Rennes Fondation (10% Owner) Buy 2,200 4.98 10,956
2018-12-26 Mckenzie W Thorpe (Director) Buy 3,600 5.00 17,996
2018-12-24 Mckenzie W Thorpe (Director) Buy 24,838 5.88 146,097
2018-12-21 Rennes Fondation (10% Owner) Buy 4,200 6.24 26,208
2018-12-19 Simard John (Chief Executive Officer) Option Ex 50,000 2.50 125,000
2018-11-12 Mckenzie W Thorpe (Director) Buy 700 3.75 2,625
2018-11-09 Mckenzie W Thorpe (Director) Buy 2,200 3.73 8,217
2018-10-04 Mckenzie W Thorpe (Director) Sale 385,000 3.00 1,155,000
2018-09-26 Mckenzie W Thorpe (Director) Sale 17,634 3.05 53,801
2018-09-13 Mckenzie W Thorpe (Director) Sale 7,909 3.10 24,549
2018-09-12 Mckenzie W Thorpe (Director) Sale 41,675 3.06 127,567
2018-09-10 Mckenzie W Thorpe (Director) Sale 23,369 3.22 75,341
2018-09-07 Mckenzie W Thorpe (Director) Sale 6,234 3.65 22,760
2018-09-05 Mckenzie W Thorpe (Director) Sale 7,220 3.94 28,482
2018-09-04 Mckenzie W Thorpe (Director) Sale 3,800 4.00 15,181
2018-08-10 Mckenzie W Thorpe (Director) Sale 3,171 3.98 12,623
2018-08-09 Mckenzie W Thorpe (Director) Sale 6,638 4.00 26,525
2018-08-08 Mckenzie W Thorpe (Director) Sale 4,000 4.01 16,024
2018-08-07 Mckenzie W Thorpe (Director) Sale 8,452 3.94 33,334
2018-08-06 Mckenzie W Thorpe (Director) Sale 3,340 3.99 13,326
2018-08-03 Mckenzie W Thorpe (Director) Sale 23,900 3.96 94,691
2018-08-02 Mckenzie W Thorpe (Director) Sale 30,461 3.92 119,528
2018-08-01 Mckenzie W Thorpe (Director) Sale 8,163 4.25 34,651
2018-07-31 Mckenzie W Thorpe (Director) Sale 6,531 4.49 29,317
2018-07-30 Mckenzie W Thorpe (Director) Sale 5,344 4.41 23,540
2018-03-23 Han Queena (VP Finance & HR) Sale 8,201 4.75 38,954
2018-03-23 Han Queena (VP Finance & HR) Option Ex 8,201 2.50 20,502
2018-03-22 Han Queena (VP Finance & HR) Sale 62,200 4.76 296,134
2018-03-22 Han Queena (VP Finance & HR) Option Ex 62,200 2.50 155,500
2018-03-21 Han Queena (VP Finance & HR) Sale 9,599 4.48 42,984
2018-03-21 Han Queena (VP Finance & HR) Option Ex 9,599 2.50 23,997
2017-05-24 Simard John (Chief Executive Officer) Option Ex 240,000 .93 223,680
2016-11-15 Han Queena (VP Finance & HR) Sale 19,573 15.00 293,595
2016-11-15 Han Queena (VP Finance & HR) Option Ex 19,573 .74 14,484
2016-09-08 Han Queena (VP Finance & HR) Sale 427 15.00 6,405
2016-09-08 Han Queena (VP Finance & HR) Option Ex 427 .77 328
2016-05-26 Mckenzie W Thorpe (Director) Buy 20,000 13.96 279,120
2016-05-20 Mckenzie W Thorpe (Director) Buy 1,500 13.75 20,619
2015-12-22 Han Queena (VP Finance / HR) Sale 10,000 10.27 102,739
2015-12-22 Han Queena (VP Finance / HR) Option Ex 10,000 .72 7,200
2015-12-21 Han Queena (VP Finance / HR) Sale 10,000 10.38 103,750
2015-12-21 Han Queena (VP Finance / HR) Option Ex 10,000 .72 7,200
2015-12-18 Han Queena (VP Finance / HR) Sale 10,000 10.78 107,820
2015-12-18 Han Queena (VP Finance / HR) Option Ex 10,000 .72 7,200
2015-11-16 Stecher Michael (Medical Director) Sale 1,800 14.00 25,200
2015-11-16 Stecher Michael (Medical Director) Option Ex 1,800 5.00 9,000

Insider trading activities including stock purchases, stock sales, and option exercises of XBIT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xbiotech Inc. (symbol XBIT, CIK number 1626878) see the Securities and Exchange Commission (SEC) website.